Search filters

List of works by Lucas Moreno

A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project

scientific article published on 18 November 2020

A phase I trial of AT9283 (a selective inhibitor of aurora kinases) in children and adolescents with solid tumors: a Cancer Research UK study

scientific article

About the Benefits of Immunotherapy for High-Risk Neuroblastoma

scientific article published on January 7, 2013

Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Euro

scientific article published on 12 June 2017

CN133, a Novel Brain-Penetrating Histone Deacetylase Inhibitor, Hampers Tumor Growth in Patient-Derived Pediatric Posterior Fossa Ependymoma Models

scientific article published on 16 July 2020

ECLIM-SEHOP, a new platform to set up and develop international academic clinical trials for childhood cancer and blood disorders in Spain

scientific article published on 09 October 2019

Early phase clinical trials of anticancer agents in children and adolescents - an ITCC perspective

scientific article

Glioblastoma, 47XXY/45,X mosaicism, and hyperpigmented skin lesions

scientific article published on 16 July 2018

How can attrition rates be reduced in cancer drug discovery?

scientific article published on 04 February 2013

How to address challenges and opportunities in pediatric cancer drug development?

scientific article published on 18 May 2020

Improving the quality of care in the molecular era for children and adolescents with medulloblastoma

scientific article published on 01 April 2019

Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic

scientific article published on 16 July 2020

Institutional Experience With Clofarabine and Cytarabine in Relapsed Pediatric Acute Myeloid Leukemia

scientific article published on 01 January 2012

Is there a role for high dose chemotherapy with hematopoietic stem cell rescue in patients with relapsed supratentorial PNET?

scientific article published on August 18, 2011

Long-term analysis of children with metastatic neuroblastoma treated in the ENSG5 randomised clinical trial

scientific article published on 05 December 2018

Long‐term follow‐up of children with high‐risk neuroblastoma: The ENSG5 trial experience

scientific article published on December 31, 2012

MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic Treatment

scientific article published on 15 March 2019

Management and outcome of children and adolescents with non-medulloblastoma CNS embryonal tumors in Spain: room for improvement in standards of care.

scientific article

Methodological advances in the discovery of novel neuroblastoma therapeutics

scientific article published on 22 November 2021

Noninvasive MRI native T1 mapping detects response to MYCN-targeted therapies in the Th-MYCN model of neuroblastoma

scientific article published on 28 June 2020

Opportunities and Challenges in Drug Development for Pediatric Cancers

scientific article published on 04 December 2020

Targeted approaches to childhood cancer: progress in drug discovery and development

scientific article published on 03 April 2015

The challenge of defining "ultra-high-risk" neuroblastoma

scientific article published on 26 November 2018

The development of targeted new agents to improve the outcome for children with leukemia

scientific article published on 27 September 2016

Using different schedules of Temozolomide to treat low grade gliomas: systematic review of their efficacy and toxicity

scientific article published on 05 July 2011